Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model

Alikhani, N, Ferguson, R D, Novosyadlyy, R, Gallagher, E J, Scheinman, E J, Yakar, S, LeRoith, D·2013·Oncogene
DOI 10.1038/onc.2012.113

Cited by (146)

Items 101–146 of 146

  1. Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells
    Bendre, Shruti V., Wang, Yu, Hajyousif, Basel, K C, Rajendra, Bhogale, Shounak G., Pradeep, Dhanya, Krawczynska, Natalia, Schane, Claire P., Weisser, Erin, Singh, Avni et al. · 2026 · Science Advances
  2. APOE Drives Glioma Progression by Modulating CCL5/CCR5 Signaling in the Tumor Microenvironment and Inducing M2 Macrophage Polarization
    Wei Huang, Weimin Li, Xingyu Chen, Chengwei Xiang, Ke Luo · 2025 · Immunobiology
  3. The impact of obesity and lipids on cancer: Insights into mechanisms and potential interventions
    Montserrat Romero, Yifan Lian, Albert Piquer, Núria Borràs-Ferré, Antonio Zorzano A, Saška Ivanova · 2025 · Seminars in Cancer Biology
  4. Diabetes, Antihyperglycemic Medications and Cancer Risk: Smoke or Fire?
    Emily J. Gallagher, Derek LeRoith · 2013 · Endocrine Practice
  5. Lack of association of poultry and eggs intake with risk of non-Hodgkin lymphoma: a meta-analysis of observational studies
    Youhong Dong, Gang Wu · 2016 · European Journal of Cancer Care
  6. Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study
    Rita Peila, Thomas E. Rohan · 2023 · International Journal of Cancer
  7. Circulating lipids, lipid-lowering drug targets, and breast cancer risk: Comprehensive evidence from Mendelian randomization and summary data-based Mendelian randomization
    Zhongxu Zhang, Daxin Zhang · 2024 · Cancer Causes & Control
  8. Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population
    Caroline Goupille, Lobna Ouldamer, Michelle Pinault, Cyrille Guimares, Flavie Arbion, Marie Lise Jourdan, Philippe G. Frank · 2020 · Journal of Nutrition
  9. Role of Protein Regulators of Cholesterol Homeostasis in Immune Modulation and Cancer Pathophysiology
    Wang, Yu, Bendre, Shruti V, Krauklis, Steven A, Steelman, Andrew J, Nelson, Erik R · 2025 · Endocrinology
  10. Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
    S. T. Karvelsson, Qiongzi Wang, B. Hilmarsdottir, Arnar Sigurdsson, S. Moestue, G. Mælandsmo, S. Halldorsson, Steinn Gudmundsson, Ó. Rolfsson · 2021 · npj Systems Biology and Applications
  11. Cholesterol and Radiosensitivity
    Omar M. Rahal, Wendy A. Woodward · 2016 · Current Breast Cancer Reports
  12. Identifying the differentially expressed microRNAs in esophagus squamous cell carcinoma of Kazakh patients in Xinjiang
    Liyun Cheng, Guijun Shi, Chunxiao Fang, Guanghua Li, Zheng Yong, Weigang Chen · 2019 · Oncology Letters
  13. Tylophora yunnanensis extract inhibits cholesterol biosynthesis to suppress triple negative breast cancer
    Zhihui Feng, Wen-Yue Li, Qizhang Li, Fengbo Zhao, Haijun Zhang, Lei Zhang, Hong Zhang · 2025 · Journal of Ethnopharmacology
  14. Protective role of All Trans Retinoic Acid on B16F10 melanoma cell line metastasis in C57BL/6 mice by enhancing RAR- β protein and homeostasis maintenance
    V. M. Berlin Grace, S. Saranya, D David Wilson · 2021 · Journal of Histotechnology
  15. High Risk of Metabolic Dysfunction in Nonobese Breast Cancer Survivors
    Pedro Paulo P da Silva-Filho, Daniel de Araújo Brito Buttros, Luciana de Araújo Brito Buttros, Giulliano Esperança, Pedro Luiz F Gubolino, Eduardo Carvalho Pessoa, Heloísa De Luca Véspoli, Eliana Aguiar Petri Nahás · 2025 · Clinical Breast Cancer
  16. Insulin and Insulin-Like Growth Factor-1 Associated Cancers
    Sanjay Kumar Dey, Sabyasachi Senapati · 2021 · Springer eBooks
  17. Bird’s eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes
    Shinkichi Kosaka, Minoru Miyashita, Keely McNamala, Miyuki Nomura, Hiroshi Shima, Masaaki Kawai, Ikuro Sato, Narumi Harada‐Shoji, Takanori Ishida, Man Ho Choi et al. · 2022 · The Journal of Steroid Biochemistry and Molecular Biology
  18. The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
    Emily J. Gallagher, Brian A. Neel, Irini Markella Antoniou, Shoshana Yakar, Derek LeRoith · 2017 · Springer eBooks
  19. VEGFA and APOE regulate distinct functional states of mast cells in hepatocellular carcinoma: A single-cell transcriptome analysis
    Xiang Lv, Jianlin Chen, Xieyidai Abuduhailili, Yuqin Deng, Xia Yuan, Yangchun Feng · 2025 · International Journal of Biological Macromolecules
  20. Hypercholesterolemia and the role of lipid metabolism gene CES1 in immune infiltration promote central nervous system relapse in acute myeloid leukemia
    Wanwan Bao, Yansong Tu, Shan Zhang, Xiaoyan Jiang, Huijun Chen, Huaijun Tu, Jian Li · 2025 · Frontiers in Immunology
  21. Impact of exercise-based prehabilitation on cardiometabolic health in surgical patients with cancer: a systematic review and meta-analysis
    Manuel Fernández-Escabías, Javier Jurado, Sofía Carrilho-Candeias, Andrea Orellana-Jaen, Pablo Corres, Andrés Mármol-Pérez, Carl J. Lavie, Almudena Carneiro‐Barrera, Teresa Nestares, Francisco J. Amaro‐Gahete · 2025 · Supportive Care in Cancer
  22. Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors
    Xin Lou, Yihua Shi, Yi Qin, Wuhu Zhang, Ye Zeng, Fei Wang, Yan Wang, Tian Ding, Desheng Jing, Guixiong Fan et al. · 2025 · Cell Death and Disease
  23. Inhibition of P110α and P110δ catalytic subunits of PI3 kinase reverses impaired arterial healing after injury in hypercholesterolemic male mice
    Pinaki Chaudhuri, Andrew H. Smith, Linda M. Graham, Michael A. Rosenbaum · 2021 · American Journal of Physiology-Cell Physiology
  24. Association between pathologic complete response and biochemical indicators after neoadjuvant therapy for HER2-positive breast cancer
    Wei Chen, Jing Zhang, Fenxiang Li, Zongshun Chen, Junjie Li, Da‐Lin Lu · 2024 · World Journal of Surgical Oncology
  25. Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy
    Youzhao Ma, Jingyang Zhang, Dechuang Jiao, Xiuchun Chen, Zhenzhen Liu · 2024 · Cancer Medicine
  26. Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction
    Alicia Álvarez-Álvarez, M. Guadalupe Fernández, Guadalupe Ortiz-Muñoz · 2026 · Seminars in Cancer Biology
  27. Obesitateak minbizia izateko arriskua handitzen du... Zer mekanismo daude tartean?
    Saioa Zorita, Jenifer Trepiana, Itziar Eseberri, María P. Portillo · 2020 · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria
  28. The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
    Emily J. Gallagher, Brian A. Neel, Irini Markella Antoniou, Shoshana Yakar, Derek LeRoith · 2017 · Springer eBooks
  29. DHCR24 Promotes Melanoma Stem-Like Cells Formation and Mediates Vemurafenib Resistance by Accumulating 27-Hydroxycholesterol
    Feiliang Zhong, Tingting Chen, Jia Liu, Ying Wang, Mingdong Yao, Bo Li · 2021 · Research Square
  30. Hypercholesterolemia promotes the intravasation of breast tumor cells through an LDL-LDLR axis
    Ana Magalhães, Vanessa Cesário, Diogo Coutinho, Inês Matias, Germana Domingues, Catarina Pinheiro, Teresa L. Serafim, Sérgio Dias · 2022 · Research Square
  31. LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironment
    Yu Wang, Bryan Duong, S. Keeley, Natalia Krawczynska, Shruti V. Bendre, Claire P. Schane, Erin Weisser, N. Cobo-Vuilleumier, Lara I. Kockaya, Yi-Fan Fei et al. · 2025 · bioRxiv
  32. NOVEL THERAPEUTIC TARGETS IDENTIFIED BY HIGH-THROUGHPUT TECHNOLOGIES FOR TRIPLE-NEGATIVE BREAST CANCER
    Christine Y. Shiang · 2013 · Digital Commons-TMC (Texas Medical Center)
  33. The Influence of Exercise and Hyperlipidaemia on Breast Cancer
    Linda A. Buss · 2016 · Otago University Research Archive (University of Otago)
  34. The immune system: A common link mediating exercise effects on the tumour microenvironment and skeletal muscle mitochondria?
    Linda A. Buss · 2020 · Otago University Research Archive (University of Otago)
  35. The role of systemic metabolism in breast cancer progression
    Catarina Sofia Rodrigues dos Santos Granja da Fonseca · 2015 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  36. Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile
    Haitao Huang, Xueyou Zhang, Cheng Zhang, Qi Ling, Shusen Zheng · 2020 · World Journal of Gastroenterology
  37. The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
    Emily J. Gallagher, Brian A. Neel, Irini Markella Antoniou, Derek LeRoith · 2016 · Springer eBooks
  38. Nutritional factors and metabolic biomarkers: impact in risk and survival of women with breast cancer
    Isabelle Romero Novelli · 2022
  39. Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment
    Dipti Athavale, Himanshi Yaduvanshi, Firoz Khan Bhati, Shyamananda Singh Mayengbam, Tushar H. More, Srikanth Rapole, Manoj Kumar Bhat · 2026 · Journal of Biosciences
  40. Additional file 2 of NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway
    Siyi Ning, Caiying Liu, Kangtao Wang, Yubo Cai, Zhicheng Ning, M.-Y. Li, Zeng, Liang · 2023 · Figshare
  41. Additional file 1 of NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway
    Siyi Ning, Caiying Liu, Kangtao Wang, Yubo Cai, Zhicheng Ning, M.-Y. Li, Zeng, Liang · 2023 · Figshare
  42. Cibler l'homéostasie du cholestérol cellulaire pour traiter le cancer du sein
    Celine Ben Hassen · 2019
  43. Etude du mécanisme d'action d'un onco-métabolite impliqué dans la prolifération des cancers du sein triple-négatifs
    Arnaud Mallinger · 2019
  44. Association between serum chemerin and breast cancer mediated by lipid metabolism
    Hui Li, Qunying Xu, Mingquan Huang, Jing Shu, Siyi Chen, Jia Xia, Ya Liu, Yunli Ye · 2026 · Discover Oncology
  45. Cholesterol‐Lowering Treatment Blocks Epithelial‐Mesenchymal Transition ( EMT ) Associated Invasiveness and Drug Resistance in Breast and Colorectal Adenocarcinoma Models
    Shanen Perumal, Naaziyah Abdulla, Ruth Aronson, Mandeep Kaur · 2026 · Cancer Medicine
  46. LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironment
    Yu Wang, Bryan Duong, Sam Keeley, Natalia Krawczyńska, Shruti V. Bendre, Claire P. Schane, Dhanya Pradeep, Desirée Rodriguez-Casiano, Erin Weisser, Nadia Cobo Vuilleumier et al. · 2026 · Cancer Letters